*Some titles are tentative. Speakers and titles are subject to change.
|
Tuesday June 12, 2012
|
|
Session
|
Topic
|
Speaker
|
Company
|
Time
|
|
REGISTRATION
|
|
|
7:30 - 8:30
|
|
|
Conference Opening
|
Maria Fitzgerald
|
Genzyme
|
8:30 - 8:40
|
|
Opening Plenary
|
What's Good and What Could
Be Better in HT-ADME?
|
Ron White
|
XenoBiotic Laboratories
|
8:40 - 9:25
|
|
SESSION I: Transporters
|
|
Session I Introduction |
|
|
9:25 - 9:35
|
|
The What, When, and Why of Drug Transporters: Strategies Across Discovery and Development
|
Dan Bow |
Abbott Laboratories |
9:35 - 10:05
|
|
Tools to Predict Hepatobiliary Drug Disposition, Intracellular Concentrations
and Hepatotoxicity
|
Kim Brouwer
|
University of North Carolina
|
10:05 - 10:35
|
|
BREAK
|
10:35 - 10:50
|
|
Transporter Strategies in a Dynamic Landscape: Industry Perspective
|
Praveen Balimane
|
Bristol-Myers Squibb
|
10:50 - 11:20
|
|
SESSION II: Technology Enabling HT-ADME
|
|
Session II Introduction
|
|
|
11:20 - 11:30
|
|
Development and Application of ADDA: A new integrated LC/MS/MS platform for drug discovery bioanalysis
|
Hui Zhang
|
Pfizer
|
11:30 - 12:00
|
|
RapidFire MS for ADME applications
|
Wentao Zhang
|
Exelixis
|
12:00 - 12:30
|
|
Cassette Incubation followed by Bioanalysis using High Resolution Mass Spectrometry for in-vitro Screening Assays
|
Jun Zhang
|
Bristol-Myers Squibb
|
12:30 - 1:00
|
|
LUNCH
|
1:00 - 2:00
|
|
Vendor Presentation
|
|
|
Sigma Life Science |
2:00 - 2:30
|
|
SESSION III: HT-ADME Met ID Early On
|
|
Session III Introduction |
|
|
2:30 - 2:40
|
|
Software Automation Tools for High Content Metabolic Stability Screening in Early Drug Discovery
|
Veronica Zelesky |
Pfizer
|
2:40 - 3:10
|
| BREAK |
3:10 - 3:30
|
|
Metabolic Stability and Metabolic Profiles
|
Jonathan Josephs |
Bristol-Myers Squibb |
3:30 - 4:00
|
|
Panel Discussion:
HT-ADME Met ID Early On
|
Ragu Ramanathan (moderator), Jonathan Josephs, Ron White
|
|
4:00 - 4:30
|
|
Networking Reception
|
4:30 - 5:30
|
|
